Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Research On HIV Vaccine To Move Soon To Phase-II Stage

This article was originally published in PharmAsia News

Executive Summary

Chinese scientists say they have received government approval to launch Phase II clinical trials of an HIV vaccine they developed

Chinese scientists say they have received government approval to launch Phase II clinical trials of an HIV vaccine they developed.

The vaccine created by the National Center for AIDS/STD Control and Prevention recently passed Phase I trials. The vaccine, which relies on a smallpox vaccine as a carrier, is expected to move into second-phase trials within the next four months, according to the chief expert for the center. (Click here for more)

"Scientists Get Step Closer To HIV Vaccine" - China Daily (4/4/11)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel